chrisvoncsefalvay/vaers-outcomes huggingface dataset:
44 yo female with PMHx of HTN and HLD with allergies to PCN and Decadron presented to community today (6/4/21)with her husband for 2nd dose of Pfizer vaccine. Pt states she did not have an adverse reaction to the 1st dose. Pt had an adverse reaction to her 2nd dose given at 1:03pm on 6/4/21. At approximately 1:26pm, patient started having a headache, rated 8/10, radiating down the back of her neck. Vitals obtained at 1:41pm: HR 98, O2 sat 96%, BP 130/90.  Patient denied SOB, CP, difficulty breathing, vision changes. When patient stood up, she reported dizziness and lightheadedness with no relief of headache. EMS called and vitals repeated, vitals stable. Pt noted to have  4 episodes of emesis, however pt's husband believes emesis to be unrelated to today's events due to pt having a history of emesis episodes for the past several weeks and is being followed by a doctor for it. EMS arrived, vitals obtained again, vitals stable. EKG performed by EMS. EMS transported patient the hospital.
This spontaneous report has been received from a registered nurse and concerns a multiple unspecified patients of unknown age and gender. There was no information about patients' concomitant medications and pertinent medical history reported. On an unknown dates, the patients were vaccinated with unspecified doses of improperly stored VAQTA lot # K012457, expiry date 04-JUN-2017 or lot # L023232 expiry date 25-FEB-2017 or lot # L023936, expiry date 15-MAR-2017 (dose, strength, route and site of administration were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Initial report received from a health care professional on 31 Dec 2009: This patient, with an unknown medical history was inadvertently administered FLUVIRIN, intramuscularly on an unspecified date. The outcome of the event was not reported. No other information was provided.
bloating; burping; diarrhea; This is a spontaneous report from a contactable physician reported for 2 patients, this is for the 2nd of the 2 patients.  A 50-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 25Apr2021 (at the age of 50-year-old) (Batch/Lot number was not reported) as 2ND DOSE, SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (Solution for injection) on an unknown date for covid-19 immunization. It was reported that, Patient received her 2nd Pfizer vaccine dose on 25Apr21, Since her 2nd dose she experienced bloating, burping and diarrhea for over a month now, on an unspecified date. Physician reported that, Patient had no pain and her abdominal ultrasound was normal. Also reported that, If that continued, Physician would do CT scan in couple of weeks but he thought it was related to the vaccine. Ethylene Glycol is an ingredient and it is stool softener. So that all made sense." Outcome of the events was not recovered.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) :  same reporter/drug/AE with different patient
Wednesday Night I started feeling slightly dizzy with  a seeming loss of equilibrium.  When I woke Thursday morning I felt a slight numbness and tingling in the left side of my face.  My left ear felt "full" After my second dose on Saturday, April 3,  at 8:35 a.m., Starting Wednesday, April 7  around 7:00 p.m., I experienced a slightly more serious facial tingling and numbness, including tongue on the left side.  This feeling was continuous for several days and is currently coming and going.   Tingling and numbness continues and my ear still feels full today, April 13
Chills - ~12h Low fever: ~24h Muscle and joint pain: ~5 days Strong headaches, fatique: 7 days
extreme exhaustion; This case was reported by a consumer via interactive digital media and described the occurrence of exhaustion in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced exhaustion. On an unknown date, the outcome of the exhaustion was recovered/resolved.   It was unknown if the reporter considered the exhaustion to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. After received the 2nd dose of Shingrix the patient experienced extreme exhaustion which lasted almost 2 days. The patient asked was this part of the side effects.
sore arm; Initial information regarding this unsolicited valid non-serious social media case was received from a consumer (patient) and transmitted to Sanofi on 01-Nov-2020.  This case involved a patient of unknown demographics who had sore arm (pain in extremity), while the patient received vaccine INFLUENZA VACCINE.  Relevant medical history, past medical treatment, vaccination, concomitant medications and family history were not provided   On an unknown date, all the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sore arm (pain in extremity), unknown latency following the administration of INFLUENZA VACCINE.  Relevant laboratory test was not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  There will be no information available on batch number for this case.
This case was reported by a physician via sales rep and described the occurrence of injection site pain in a female patient who received BEXSERO. Concomitant products included MENVEO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced injection site pain and injection site swelling. On an unknown date, the outcome of the injection site pain and injection site swelling were recovering/resolving. The reporter considered the injection site pain to be related to BEXSERO. It was unknown if the reporter considered the injection site swelling to be related to BEXSERO. Additional details were reported as follows: The reporter reported that his daughter was administered BEXSERO in his office and experienced the events. The field rep wasn't sure if it was the physician himself or a staff member, who administered the vaccine to the patient. The field representative was not certain about the concomitant vaccine but thought it was MENVEO. It was reported that the onset date was not known but field representative said it was recently occurred. The events were better but not completely gone.
Patient presented to the post Covid-19 vaccine observation room. Pt c/o red spots and mild itching to the abdominal area 20 minutes s/p injection. Pt was assessed and vitals taken as noted. Pt was transported via wheelchair to the express care department for further assessment and treatment. This incident took place in observation area.
Patient first received 1st Covid vaccine in an adjacent County, receiving Moderna on X/XX/2021. At our vaccination clinic, patient received Pfizer vaccine on X/XX/2021 (27 days after). There were no known side-effects.
On routine exam in September 2021, after receiving Pfizer vaccine booster in August 2021, patient noted to have thyroid antibodies, elevated TSH and low T4.  He was Rx'd levothyroxine 75 micrograms a day with follow-up in three months.  Patient had normal THS and T4 in 2020 and for the preceeding seven years.
Dr.'s office records indicate they failed to properly report administered vaccines causes health department to have inaccurate information and re-vaccinate patient 4 months later thinking he was missing vaccines. As a result he is having more than normal adverse reactions.
PATIENT WOKE UP MORNING AFTER VACCINATION WITH SORE ARM AND A RED, IRRITATED/ITCHY CIRCLE THE SIZE OF A NICKLE AT THE INJECTION SITE. IT DID GROW LARGER AS THE DAY WENT ON. PATIENT CALLED THE PHARMACY - WAS ADVISED BY PHARMACIST TO TRY A DAY OF BENADRYL AND KEEP TRACK IF THE MARK DECREASED IN SIZE AND IRRITATION. AFTER 2 DAYS ON BENADRYL THE PATIENT HAD RELIEF OF SYMPTOMS AND AFTER 4 DAYS ON BENADRYL, THE PATIENT HAD SAID THE MARK WAS GONE. PHYSICIAN NOT CONTACTED.
diahrea; Fever up to 102; uncontrollable chills; muscle aches and contraction; muscle aches and contraction; joint aches and stiffness; joint aches and stiffness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Feb2022 12:15 (Lot number: FM0698) at the age of 50 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Psoriatic Arthritis" (unspecified if ongoing); "Psoriasis" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Psoriasis" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Concomitant medication(s) included: COSENTYX; CITALOPRAM; AMLODIPINE BESYLATE; ROPINIR. Past drug history included: Iodine, reaction(s): "known allergies: iodine". Vaccination history included: Bnt162b2 (Prev dose product=COVID 19, Prev dose brand=Pfizer, Prev dose brand unknown=False, Prev dose lot number=EW0170, Prev dose lot unknown=False, Prev dose administration date=01Jul2021, Prev dose number=2, Prev dose vaccine location=Left arm), administration date: 01Jun2021, when the patient was 49 years old, for COVID-19 immunization; Bnt162b2 (Prev dose product=COVID 19, Prev dose brand=Pfizer, Prev dose brand unknown=False, Prev dose lot number=EW0170, Prev dose lot unknown=False, Prev dose administration date= 11May2021, Prev dose number=1, Prev dose vaccine location=Left arm), administration date: 11May2021, when the patient was 49 years old, for COVID-19 immunization. The following information was reported: DIARRHOEA (non-serious) with onset 12Feb2022 22:00, outcome "not recovered", described as "diahrea"; PYREXIA (non-serious) with onset 12Feb2022 22:00, outcome "not recovered", described as "Fever up to 102"; CHILLS (non-serious) with onset 12Feb2022 22:00, outcome "not recovered", described as "uncontrollable chills"; MYALGIA (non-serious), MUSCLE CONTRACTIONS INVOLUNTARY (non-serious) all with onset 12Feb2022 22:00, outcome "not recovered" and all described as "muscle aches and contraction"; ARTHRALGIA (non-serious), JOINT STIFFNESS (non-serious) all with onset 12Feb2022 22:00, outcome "not recovered" and all described as "joint aches and stiffness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of diarrhoea, pyrexia, chills, myalgia, muscle contractions involuntary, arthralgia, joint stiffness. No follow-up attempts are possible. No further information is expected.
The vaccinee reportedly had no pre-existing medical conditions. Reportedly, he "never had arthritis before and none in family history". He reported that he believed injections of Lymerix on 10/25/99 (lot LY130B9) and 12/6/99 (lot LY130A9). He stated that on 12/7/99, he received influenza virus vaccine (Fluzone; lot 40436AA). He stated that he first noticed "severe" pain in his right hip in 11/00. Reportedly, an X-ray was performed in 11/00 that showed arthritis. The vaccinee stated that he received his third injection of Lymerix (lot LY145A9) on 12/8/00. On that date, he also received an injection of influenza virus vaccine (Fluzone; lot 4036AA0). The vaccinee reported that he underwent MRI in 2/01; results were not provided. The vaccinee reported that an X-ray performed in 5/01 "showed arthritis is much worse". The vaccinee's attorney alleged that "as a result of (the vaccinee's) use of (Lymerix), he developed severe autoimmune arthritis in the right hip first dx'd in 11/00 and has been seen by an orthopedic surgeon and a rheumatologist and hip joint replacement is anticipated." The vaccinee reported that he "can only walk with crutches". On a VAERS form that he completed, the vaccinee indicated that the event resulted in permanent disability.  Follow up on 12/12/2003: "The following information was provided by the pt's medical records.  The pt was referred by his orthopaedic physician for physical therapy evaluation and therapy.  Treatment noted dates 12/05/2000, indicated that the pt had a diagnosis of osteoarthritis in his right hip.  The hip pain onset began in August 2000.  His physical therapy treatment included moist heat, cold packs, electric muscle stimulation, soft tissue mobilization, ultrasound, and exercises.  He was prescribed Celebrex and was subsequently switched to Vioxx with good results.  By 12/15/2000, the pt reported that his hip pain was improving.  The most recent information received on 11/26/03 did not provide the outcomes of the reported events."
This spontaneous report has been received from a registered nurse referring to a patient of unknown age and gender.  Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not reported. On 25-JAN-2018, the patient was vaccinated with an improperly stored dose of M-M-R II lot # N027780, expiration date 08-AUG-2019, by subcutaneous route, for prophylaxis (strength and anatomical location were not provided). The vaccine was exposed to a temperature range of 17°C, during a time frame of 6 hours. No adverse effects were reported.
Red hot arm. Sore. Redness getting bigger. Very lethargic. Headache. Feeling of nausea. Shaking. Dizziness.
Information has been received from a physician concerning a 25 year old female who on 17-DEC-2007 was vaccinated with her second dose of GARDASIL. Concomitant therapy included influenza virus vaccine (unspecified) (INFLUENZA VIRUS VACCINE USP). On 17-DEC-2007 the patient experienced dizziness, nausea, nose bleeding and fainted. The patient sought unspecified medical treatment. Subsequently, the patient recovered from dizziness, nausea, nose bleeding and fainting on the same day. The patient did not have an adverse event with the first dose. Additional information has been requested.
LOUD buzzing in head, faintness, dizzyness, all over muscle aches, too many migraines in one month, unable to sleep because of restlessness in entire body. The night of the injection, it was like I could literally feel my blood surging through my body and the whole room was spinning. These symptoms have persisted in one way or another since Jan 29th and I can not get peace!
This spontaneous report was received from a registered nurse and refers to an unspecified patient of unknown age and gender. There was no information about the patient's current condition, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with a dose of an improperly stored dose of VARIVAX subcutaneous injection (possible lots of dosed vaccine was reported as: lot# M022103 with an expiration date: 04-MAY-2018; lot# M019643 with an expiration date: 20-APR-2018, lot # M009766 with an expiration date: 23-FEB-2018, lot# M002061 with an expiration date: 12-JAN-2-2018) (dose, frequency and route of administration were not reported). The reporter was unable to determine from which lot of VARIVAX the administered dose came. Administered dose of VARIVAX experienced temperature excursion of -7.4 Celsius degree for 55 minutes, on an unknown date. No adverse effects were reported. Additional information has been requested.
arm soreness; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from a sponsored program Corporate Social Media Platforms for a Pfizer sponsored program.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm soreness".  Additional information: (As reported) Thank you Pfizer! My husband and I had our first snots already and we only had arm soreness for a day or so. Second shots on 4/31 1 nave allergies that require me to carry an epi pen and I had no allergic reaction at all.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021319541 Same reporter, different patient
4/1 arm pain. 4/2 very tired, muscle & joint pain, headache. 4/3 little pain when lifting right arm, headache. 4/4 soreness under left breast on ribs, headache. 4/5 started with chills during morning, sudden severe pain lower left abdomen to my back, nausea/vomitting, pain was so severe I had to go to the ER. This event lasted over 3 hrs. 4/6 recurring headache. 4/7 headache, 4/8 headache, little discomfort in stomach, 4/9 headache, little discomfort in stomach.
Diarrhea, headaches, painful swollen lymphnodes, fatigue, rash on chest, neck, face, and back.
Fatigue, muscle pain all over, slightly headachy, arm soreness, general crappy feeling.
hot; itchy; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot), PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002BZ1A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), LEVOTHYROXINE SODIUM (SYNTHROID), CELECOXIB (CELEXA [CELECOXIB]), BUPROPION HYDROCHLORIDE (WELLBUTRIN), INDAPAMIDE, LOSARTAN POTASSIUM (COZAAR), CIMETIDINE, ALLOPURINOL, POTASSIUM CHLORIDE, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot), PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE WARMTH (hot), PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Upon internal review on 24-May-2021, age was corrected to unknown.
child came in office to recieved  Bivalent booster - child was given 0.25 mL should have been given 0.5 m L. Will return in  two months for correct dosage.
Received flu vaccine in left deltoid. Within 30 min. vaccination site became reddened, warm to the touch. No hives or difficulty breathing. Area on arm continued to worsen in the next 48 hours. Referred to urgent care. Pt. received prednisone 50 mg x 5 days.
Positive flu test after Fluarix vaccine on 10/23/2013 (Flu B).
fever. patient c/o fever, weakness, nausea that started today after recieving J&J vaccine. states took 800mg motrin prior to arrival. History:  pt s/p J&J COVID-19 vaccine at noon today here with fever, chills, occipital/neck headache, body ache, transient bilateral upper arm paresthesia, since this evening, s/p 3 pills of ibuprofen at 2200, here for eval. Takes no other meds and denies vomit/diarrhea/rash, sick contact, recent visit to COVID-19 hotspot, or co-morbidities in the past.
I received my first dose Moderna vaccine on 01-20-2021. I have history of ulcerative colitis. About 2 and a half days, or 56 hours, I had a ulcerative colitis flare-up.  I went to urgent care to see a doctor due to my racing heart beat, flare-up from my ulcerative colitis and I also had weakness and aching sensation to my bilateral legs. I also had blood diarrhea and had to be going to the rest room.
Following up covid lab results. Covid lab result updated and image upload for 7/16/21.  Did not call hotline and speak to this writer to report covid positive result. Writer called, who stated they are in contact with employer.    Hx received via email 7/16/21:  Good Afternoon All,  Employer was notified that employee tested positive for rapid COVID testing at healthcare facility on 7/15/2021. PCR testing has been scheduled for this employee 7/16 at testing location, pending PCR COVID results. Patient is a HCP in healthcare facility. Patient is fully vaccinated with Pfizer on 12/21/20 and 1/9/21. HCP request is to remain confidential for contact tracing.  HCP reported to manager on 7/15 that he had a rapid COVID test performed and it came back positive. HCP reports on 7/15 morning he had ?bad allergies? and this is not an unusual occurrence, experiencing feeling tired and nasal congestion. It was not until he left work on 7/15 that he developed body aches, diarrhea, ?100% loss of smell,? fatigue. Denies cough or SOB. HCP reports attending a kickball league, where everyone is unmasked, on 7/10. HCP reports multiple other friends who were experiencing similar symptoms on 7/15, four of which tested positive for COVID as well. Denies any known contact with COVID positive or symptomatic individuals while at the kickball league on 7/10.   The HCP confirms he worked 7/12 through 7/15. No patient contact but multiple departmental meetings with potential lapses of social distancing practices throughout the work week are reported. HCP reports wearing mask for all large in-person departmental meetings. HCP reports some of the smaller one on one meetings he cannot recall masking status of all involved. HCP reports on the evening of 7/13 having dinner with two employees for several hours unmasked and an instance at work  in the offices of heating food up on 7/15 where he was unmasked and talking to providers for ~3min and from greater than 6ft (not all providers masked).  Contact tracing has been initiated with some unanticipated contact tracing questionnaire issues. Contact tracers will be reaching out to individuals to perform thorough contact tracing assessments, even for employees who have already answered.  Thank you for your time.
Received Moderna booster on 12/14/2021. On 12/15/2021, I woke up at 6 am and went downstairs to my kitchen. While filling a cup of water at the sink, I started seeing black and felt my hands tingling. I sat at my kitchen table, laid my head down and blacked-out. A few minutes later, I got up to try to walk back upstairs to my bed. After just a few steps, I fainted again, on the floor. A few minutes later I got up again and made it upstairs to lie down. I took two ibuprofens and within 20-30 minutes, felt relatively normal again. No other symptoms experienced after the incident. I do not have a history of low blood pressure or fainting.
Patient received Influenza vaccine before the minimum age of administration. Patient was 4 months old when first Influenza vaccine received on 12/28/21. The minimum age is 6 months old. No adverse reactions reported.
Six days after receiving the vaccine a raised, slightly raw, itchy bump presented itself on chest. Seven days after receiving the vaccine dozens of raised, red, itchy bumps have appeared on various areas of the body including neck, back, abdomen, and legs.